Dusseldorf - Delayed Quote • EUR
Avenue Therapeutics Inc (49Y0.DU)
At close: April 25 at 8:12 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
14,540.00
14,540.00
8,043.00
3,738.00
5,213.00
Operating Income
-14,540.00
-14,540.00
-8,043.00
-3,738.00
-5,213.00
Net Non Operating Interest Income Expense
-206.00
-206.00
-1,140.00
7.00
62.00
Other Income Expense
4,258.00
4,258.00
5,580.00
--
--
Pretax Income
-10,488.00
-10,488.00
-3,603.00
-3,731.00
-5,151.00
Net Income Common Stockholders
-10,377.00
-10,377.00
-3,552.00
-3,731.00
-5,151.00
Diluted NI Available to Com Stockholders
-10,377.00
-10,377.00
-3,552.00
-3,731.00
-5,151.00
Basic EPS
-73.50
-0.98
-122.25
-246.75
-348.75
Diluted EPS
-73.50
-0.98
-122.25
-246.75
-348.75
Basic Average Shares
141.22
10,591.64
29.14
15.11
14.67
Diluted Average Shares
141.22
10,591.64
29.14
15.11
14.67
Total Operating Income as Reported
-14,540.00
-14,540.00
-8,043.00
-3,738.00
-5,213.00
Total Expenses
14,540.00
14,540.00
8,043.00
3,738.00
5,213.00
Net Income from Continuing & Discontinued Operation
-10,377.00
-10,377.00
-3,552.00
-3,731.00
-5,151.00
Normalized Income
-14,635.00
-14,635.00
-9,132.00
-3,731.00
-5,151.00
Interest Income
126.00
126.00
20.00
7.00
62.00
Interest Expense
332.00
332.00
1,160.00
--
--
Net Interest Income
-206.00
-206.00
-1,140.00
7.00
62.00
EBIT
-10,156.00
-10,156.00
-2,443.00
-3,731.00
-5,213.00
EBITDA
-10,156.00
-10,156.00
-2,443.00
-3,731.00
-5,213.00
Net Income from Continuing Operation Net Minority Interest
-10,377.00
-10,377.00
-3,552.00
-3,731.00
-5,151.00
Total Unusual Items Excluding Goodwill
4,258.00
4,258.00
5,580.00
--
--
Total Unusual Items
4,258.00
4,258.00
5,580.00
--
--
Normalized EBITDA
-14,414.00
-14,414.00
-8,023.00
-3,731.00
-5,213.00
12/31/2020 - 2/24/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade